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Objective: Fenestrated endovascular aortic aneurysm repair (FEVAR) is an alternative to open repair in patients with
complex abdominal aortic aneurysms who are neither ﬁt nor suitable for standard open or endovascular repair. Chimney
and snorkel grafts are other endovascular alternatives but frequently require bilateral upper extremity access that has been
associated with a 3% to 10% risk of stroke. However, upper extremity access is also frequently required for FEVAR
because of the caudal orientation of the visceral vessels. The purpose of this study was to assess the use of upper extremity
access for FEVAR and the associated morbidity.
Methods: During a 5-year period, 148 patients underwent FEVAR, and upper extremity access for FEVAR was used in 98
(66%). Outcomes were compared between those who underwent upper extremity access and those who underwent
femoral access alone. The primary end point was a cerebrovascular accident or transient ischemic attack, and the secondary
end point was local access site complications. The mean number of fenestrated vessels was 3.07 6 0.81 (median, 3) for a
total of 457 vessels stented. Percutaneous upper extremity access was used in 12 patients (12%) and open access in 86
(88%). All patients who required a sheath size >7F underwent high brachial open access, with the exception of one patient
who underwent percutaneous axillary access with a 12F sheath. The mean sheath size was 10.59F6 2.51F (median, 12F),
which was advanced into the descending thoracic aorta, allowing multiple wire and catheter exchanges.
Results:Onehemorrhagic stroke (one of 98 [1%]) occurred in theupper extremity access group, andone ischemic stroke (oneof 54
[2%]) occurred in the femoral-only access group (P[ .67). The stroke in the upper extremity access group occurred 5 days after
FEVAR and was related to uncontrolled hypertension, whereas the stroke in the femoral group occurred on postoperative day 3.
Neither patient had signs or symptoms of a stroke immediately after FEVAR. The right upper extremity was accessed six times
without a stroke (0%) compared with the left being accessed 92 times with one stroke (1%; P[ .8). Four patients (4%) had local
complications related to upper extremity access. One (1%) required exploration for an expanding hematoma after manual
compression for a 7F sheath, one (1%) required exploration for hematoma and neurologic symptoms after open access for a 12F
sheath, and two patients (2%) with small hematomas did not require intervention. Two (two of 12 [17%]) of these complications
were in the percutaneous access group, which were signiﬁcantly more frequent than in the open group (two of 86 [2%]; P[ .02).
Conclusions: Upper extremity access appears to be a safe and feasible approach for patients undergoing FEVAR. Open
exposure in the upper extremity may be safer than percutaneous access during FEVAR. Unlike chimney and snorkel
grafts, upper extremity access during FEVAR is not associated with an increased risk of stroke, despite the need for
multiple visceral vessel stenting. (J Vasc Surg 2015;61:80-7.)Fenestrated endovascular aortic aneurysm repair
(FEVAR) is rapidly becoming the standard of care for patients
with juxtarenal and short-neck aneurysms not amenable to
standard endovascular abdominal aortic aneurysm (AAA)
repair (EVAR) and in those not able to undergo an open
repair. International experience with the technique is sizable,
with excellent results.1-3 Since its induction in the United
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a sheath containing the large endograft within a groin dur-
ing the entire vessel cannulation and the necessity for can-
nulation and tracking of catheters and stents into caudally
oriented vessels from the groin.
Upper extremity access has been used in a multitude of
endovascular aortic procedures and provides a different
approach to technical success. A major route for the evalua-
tion of the coronary vasculature and for placement of stents
is through the radial artery; however, a paucity of data exist
on the prevalence of neurologic complications thereafter
and are limited to local access complications.8-10 Mesenteric
endovascular procedures, such as those for mesenteric
ischemia, have recently championed upper extremity access,
allowing an easier angle for cannulation of the vessel and
trackability of catheters and stents.11-13 Initial endovascular
techniques for the management of short-neck and juxtare-
nal aneurysms using snorkel and chimney techniques
require upper extremity access for stent placement.
Despite the initial enthusiasm, stroke rates were noted
to be between 3% and 10%.14-17 This high rate is likely due
to multiple vessels often requiring concomitant stenting or
repeated and multiple access sites used from both upper ex-
tremities. A high rate of type Ia endoleaks, given the difﬁ-
culty sealing using these techniques, has further decreased
fervor.
The purpose of this study was to assess the safety and
effectiveness of upper extremity access during FEVAR.
We hypothesized that upper extremity access could be a
useful adjunct for FEVAR, without adding morbidity.
METHODS
The University of Texas Southwestern Institutional
Review Board approved the study (STU 122011-068).
Database. A retrospective review was performed for all
patients treated at our institution for aortic pathology with
endovascular procedures during a 5-year period from 2009
to 2013. Clinical data for endovascular procedures in
patients that involved the visceral vessels were selected.
Patients undergoing open repair or those treated with
chimney stents or visceral debranching were excluded from
the study. Indications included all aortic pathology: thor-
acoabdominal, suprarenal, juxtarenal, mycotic, and chronic
dissecting aneurysms, anastomotic pseudoaneurysms, type
Ia endoleaks after previous EVAR, and penetrating
atherosclerotic ulcerations.
Demographics and clinical data were evaluated for the
group, including procedural data and imaging. Aneurysm
classiﬁcation was based on the recommended reporting
standards for aneurysm repair of the Society for Vascular
Surgery.18 A juxtarenal aortic aneurysm is deﬁned as an
aneurysm with <10 mm infrarenal aortic neck (ie, with
involvement of the aneurysmal dilatation up to the level
of the renal arteries) that originates from normal aorta.
Suprarenal aortic aneurysms involves the origin of at least
one renal artery and include pararenal aneurysms, which
involve the renal arteries but do not extend into the superior
mesenteric artery (SMA), and paravisceral aortic aneurysms,which involve the renal arteries and the SMA, but not the ce-
liac axis. Type IV thoracoabdominal aortic aneurysms
involve the origin of all four visceral arteries, including the
celiac axis, extending up to the diaphragmatic hiatus.
Postprocedural events were deﬁned as those within the
ﬁrst 30 days after the procedure. Outcomes were compared
between those who underwent upper extremity access and
those who underwent femoral access alone. The primary
end point was a cerebrovascular accident (CVA) or tran-
sient ischemic attack (TIA), and the secondary end point
was local access site complications. Patients who underwent
femoral access alone were compared with those who under-
went additional upper extremity access. The decision for
additional upper extremity access was based solely on sur-
geon preference.
Computed tomography angiography was routinely
used to evaluate the aortic arch and brachiocephalic vessels.
The visceral vessels were carefully examined, looking for
caudal angulation, thrombus, ostial stenoses, small aorta,
or any other factors that would make femoral access difﬁ-
cult and favor upper extremity access. The favorable nature
of upper extremity access was weighed against difﬁculty
with potential upper extremity access. Examination of the
arch was performed for unfavorable characteristics such as
hostile anatomy, the presence of thrombus, signiﬁcant pla-
que, or subclavian artery disease. All celiac and superior
mesenteric arteries were accessed from “above” whenever
upper extremity access was used. Selective access from
above was used for the renal arteries when a downward
orientation favored access from above or in patients who
had difﬁcult anatomy that precluded femoral access.
Operative technique. Ultrasound imaging was also
used to carefully examine the extremity vessel before ac-
cess. The brachial artery was examined for size, the pres-
ence of disease, or location of a high radial artery takeoff.
A minimum size of 4 mm was felt to be appropriate to allow
passage of a 12F sheath, which usually required high prox-
imal brachial artery access. The presence of disease or loca-
tion of a high radial artery takeoff discouraged us from use,
in which case we avoided upper extremity access or chose
the contralateral side. In patients where it was felt appli-
cable, brachial artery access was initiated before placement
of femoral sheaths and the need for heparinization. Left
sided brachial artery access was preferred, if feasible.
A small longitudinal cutdown was performed on the
medial aspect of the upper arm if a sheath >7F was
required. The brachial artery was accessed with a Micro-
puncture Access Set (Cook Medical Inc, Bloomington,
Ind). A 5F sheath was placed, a Glidewire (Terumo Med-
ical Corp, Somerset, NJ) and curved catheter were used to
cannulate the descending thoracic aorta, and a stiff Supra
Core wire (Abbot Vascular, Santa Clara, Calif) was placed.
In most cases, a 12F angled Flexor Ansel Guiding Sheath
(Cook Medical Inc) was placed and advanced into the
distal descending aorta (Fig 1).
Separate punctures of the diaphragm of the 12F sheath
were performed with an entry needle, allowing the intro-
duction of a wire. Sequential catheterization of the target
Fig 1. Fluoroscopic image shows the 12F sheath from the left
brachial access with placement in the descending thoracic aorta.
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exchanging for a stiff Rosen wire (Cook Medical Inc). Mul-
tiple wires were maintained simultaneously through the
12F sheath, as required, with up to four 0.035-inch wires
(Fig 2). Once cannulation of all vessels was complete, the
diameter-reducing ties were opened and aortic ballooning
was performed if needed. A 7F guiding sheath was
advanced sequentially over each one of these wires sepa-
rately for successive stent placement.
For catheterization of the fenestrations and target vessels
using brachial access, the fenestrated endografts were
customized with access scallops or proximal trifold conﬁgu-
ration with preloaded catheters and wires for access from
above. Alternatively, a scallop designed to accommodate
the celiac artery or the SMA can be accessed and cannulated
from below once the device has been unsheathed and used
for later access from above. For this purpose, a snare was
placed from the upper extremity access to sequentially cap-
ture the wires placed through the precannulated catheters.
The snare was pulled giving upper extremity access for the
passage of a catheter through the access scallop from above,
into the endograft, and out of the renal fenestration, allow-
ing cannulation of the target vessels. Covered Atrium iCAST
stents (Atrium Medical Corp, Hudson, NH) were placed
sequentially through 6F to 7F guiding sheaths that were
advanced through the 12F sheath.
Upon completion of the procedure, the 12F brachial
sheath was removed, nontraumatic clamps were placed,
and the vessel was repaired with interrupted 6-0 Prolene
sutures (Ethicon, Somerville, NJ). Distal pulses wereexamined. After meticulous hemostasis of the brachial inci-
sion, the subcutaneous tissue was closed, followed by the
skin with a running subcuticular stitch. Postoperatively,
the arm was serially evaluated with neurovascular checks.
Statistical analysis. Data were examined for patients
with femoral artery access and those with additional upper
extremity artery access, and outcomes were analyzed sepa-
rately. Outcomes in those with upper extremity access were
assessed by whether open or percutaneous access was used.
The major end point was CVA or TIA, suspected by the
surgical team and conﬁrmed by a neurologist’s assessment.
Minor end points included access site complications. All
statistical analyses were accomplished using GraphPad
Prism 6.0 d software (GraphPad Software Inc, La Jolla,
Calif). The Pearson c2 or Fisher exact test was used for
the comparison of categoric variables. The two-sided t-
test was used for the evaluation of differences between
means. A signiﬁcance level of P < .05 was used for all tests.
RESULTS
Among the 148 patients who underwent FEVAR, the
mean age was 68.3 6 1.6 years in the femoral access group
and 72.3 6 0.9 years in those with additional upper ex-
tremity access (P ¼ .02). Of those in the femoral access
group, 96% were male, compared with 82% in the upper
extremity access group; conversely, 4% were women in
the femoral access group and 18% were women in the up-
per extremity access group (P ¼ .02). The patient demo-
graphics and comorbidities within the two groups are
listed in Table I.
Aneurysm characteristics and previous aortic surgery
are summarized in Table II. The mean size of the aortic
aneurysm was 6.20 6 0.19 cm in the femoral access group
and 6.75 6 0.19 cm in the additional upper extremity ac-
cess group (P ¼ .068). Almost one-ﬁfth of the patients in
each group had undergone EVAR or open AAA repair
before FEVAR. Patients with a juxtarenal aneurysm,
compared with a more extensive aneurysm, were more
likely to undergo solely femoral access than an additional
upper extremity artery access (35 of 50 [70%] vs 44 of
98 [57%]; P ¼ .005).
The FEVAR procedure itself was more complex in pa-
tients who required upper extremity access. The mean
number of fenestrations was higher in the upper extremity
access group than in the femoral access group (3.256 0.08
vs 2.72 6 0.09; P ¼ .0001). The operative time and blood
loss were also signiﬁcantly higher in those who underwent
upper extremity access (Table III). However, transfusion
need and intensive care unit and total length of stay were
not different between the two groups.
Upper extremity access for FEVAR was used in 98 pa-
tients (66%), of whom 12 (12%) underwent percutaneous
and 86 (88%) open access. All patients who required a
sheath size >7F underwent high brachial open access,
with the exception of one patient who underwent percuta-
neous axillary access with a 12F sheath with a “preclose”
technique using Perclose Proglide devices (Abbott
Vascular, Redwood City, Calif). The mean sheath size
Fig 2. Brachial access depicting (top left) isolation of the brachial artery, (top right) the medial upper arm longi-
tudinal incision, (bottom left) placement of a 12F sheath, which allows placement of four 0.035-inch wires alongside
each other within the sheath, and (bottom right) placement of a 7F sheath for stent placement.
Table I. Patient demographics and comorbidities
Variablesa
Femoral access
(n ¼ 50)
Upper extremity
access (n ¼ 98) P
Demographics
Age, years 68.3 6 1.6 72.3 6 0.9 .02
Sex
Male 48 (96) 80 (82) .02
Female 2 (4) 18 (18)
Comorbidities
Hypertension 35 (70) 82 (84) .59
Smoking 32 (64) 53 (54) .29
COPD 16 (32) 41 (42) .28
Hyperlipidemia 36 (72) 69 (70) 1.0
CAD 28 (56) 66 (67) .71
CRI 5 (10) 26 (27) .85
Diabetes mellitus 6 (12) 23 (24) .13
CHF 14 (28) 26 (27) .85
CVA 4 (8) 7 (7) 1.0
CAD, Coronary artery disease; CHF, congestive heart failure (ejection
fraction <40%); COPD, chronic obstructive pulmonary disease; CRI,
chronic renal insufﬁciency (glomerular ﬁltration rate <50 mL/min/
1.73 m2); CVA, cerebrovascular accident.
aCategoric data are presented as number (%) and continuous data as mean6
standard deviation.
Table II. Size of the aneurysm, aneurysm type, and
previous aortic surgical history
Variablesa
Femoral access
(n ¼ 50)
Upper extremity access
(n ¼ 98) P
Size, cm 6.20 6 0.19 6.75 6 0.19 .068
Aneurysm type
II 2 (4) 8 (8) .5
III 1 (2) 6 (6) .42
IV 1 (2) 9 (9) .17
V 0 (0) 4 (4) .3
Suprarenal 11 (22) 27 (28) .8
Juxtarenal 35 (70) 44 (57) .005
Previous surgery
EVAR 8 (16) 19 (19) .66
TEVAR 4 (8) 10 (10) .77
Open AAA 8 (16) 22 (22) .4
Arch/hybrid 1 (2) 2 (2) 1.0
AAA, Abdominal aortic aneurysm; EVAR, endovascular aortic aneurysm
repair; TEVAR, thoracic endovascular aortic aneurysm repair.
aCategoric data are presented as number (%) and continuous data as mean6
standard deviation.
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number of vessels fenestrated was 3.07 6 0.81 (median,
3), for a total of 457 vessels stented.
One hemorrhagic stroke occurred in the 98 patients in
the upper extremity access group (1%), and one ischemic
stroke occurred in the 54 patients in the femoral-only ac-
cess group (2%; P ¼ .67). Neither patient had a history
of TIA or CVA.The stroke in the upper extremity access group
occurred in a 75-year-old woman with a 5.7-cm type V
thoracoabdominal aneurysm. She initially underwent a
thoracic endovascular aortic aneurysm repair (TEVAR)
without complication and returned 6 weeks later for the
second-stage FEVAR repair. A lumbar drain was placed
prophylactically, and she underwent a four-vessel fenes-
trated graft repair with a 12F sheath in the left brachial ar-
tery and bilateral percutaneous femoral access. She was
extubated in the operating room and was neurologically
intact. She was transiently given nicardipine for high
Table III. Operative details
Variables
Femoral access
(n ¼ 50),
mean 6 SD
Upper extremity
access (n ¼ 98),
mean 6 SD P
Fenestrations, No. 2.72 6 0.09 3.25 6 0.08 .0001
Operative time, min 258.8 6 14.1 327.1 6 10.6 .0002
EBL, mL 493.5 6 42.1 764.8 6 65.7 .0058
Transfusion 1.23 6 0.31 2.17 6 0.43 .1
Length of stay, days
ICU 3.42 6 0.65 4.20 6 0.38 .27
Total 7.34 6 1.28 7.03 6 0.47 .78
EBL, Estimated blood loss; ICU, intensive care unit; SD, standard deviation.
Fig 3. Distribution of upper extremity sheaths by size.
Table IV. Local and cerebrovascular complications by
right vs left upper extremity access
Complication
Right-sided access
(n ¼ 6), No. (%)
Left-sided access
(n ¼ 92), No. (%) P
Local complications 0 (0) 4 (4) .6
CVA 0 (0) 1 (1) .8
CVA, Cerebrovascular accident.
Table V. Local and cerebrovascular complications by
open vs percutaneous upper extremity access
Complication
Percutaneous access
(n ¼ 12), No. (%)
Open access
(n ¼ 86), No. (%) P
Local complications 2 (17) 2 (2) .02
CVA 0 (0) 1 (1) .7
CVA, Cerebrovascular accident.
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24 hours. Five days after FEVAR, she was noted to have
an elevated systolic blood pressure in the 180s, complained
of retrorbital and frontal severe headache, and became
rapidly unresponsive. She was found to have a mydriasis
and concern for herniation. A computed tomography
scan revealed a massive right occipital and posterior tempo-
ral lobe hemorrhage with midline shift. Neurologic evalua-
tion indicated that her prognosis was poor, with no means
of meaningful functional recovery, and her family subse-
quently withdrew care.
The stroke in the femoral access group occurred in a
66-year-old man who was incidentally found to have a su-
prarenal AAA on a workup for back pain. He had a his-
tory of severe coronary artery disease with angina and
severe chronic obstructive pulmonary disease. He had a
6.2-cm suprarenal aneurysm requiring fenestrations for
the SMA and both renal vessels, as well as a scallop for
the celiac artery. The procedure went well. He was extu-
bated in the operating room and was neurologically
intact. Atrial ﬁbrillation developed on postoperative day
2, and the next day was noted to have decreased strength
in his left upper extremity. A computed tomography scan
of the brain was negative, but a magnetic resonance imag-
ing revealed acute infarctions consistent with an embolic
stroke in the right posterior frontal lobe and right parietal
lobe. Carotid and cardiac ultrasound imaging were nega-
tive for a source. He was treated conservatively and was
able to proceed to rehabilitation after 5 days, and then
home after an additional week, with almost complete res-
olution of symptoms.
The right upper extremity was accessed six times
without a stroke (0%), compared with the left being
accessed 92 times with one stroke (1%; P ¼ .8;
Table IV). Four patients (4%) had local complications
related to upper extremity access. One patient (1%)
required exploration for an expanding hematoma after
manual compression for a percutaneous 7F sheath, with
primary repair and no resultant neurologic symptoms.
One patient (1%) required exploration for hematoma and
neurologic symptoms after open access for a 12F sheath.
The patient was returned rapidly to the operating room
for evacuation, with no late sequelae. Two patients (2%)
with small hematomas did not require intervention andnever had any neurologic symptoms. Two (two of 12
[17%]) of these complications were in the percutaneous ac-
cess group, which were signiﬁcantly more frequent than in
the open group (two of 86 [2%]; P ¼ .02; Table V).
DISCUSSION
Our study suggests that upper extremity access for
FEVAR is a safe approach, despite the use of large sheaths
in our series. Moreover, the added ability of access from the
upper extremity affords the interventionist a wider spec-
trum of maneuverability for successful catheterization of
the target vessels, particularly those with severe downward
angulations.
Aside from fenestrated and branched devices for the
endovascular repair of complex aortic aneurysms, chimney
and snorkel approaches have also been championed.14-17
Good immediate success has been reported; unfortunately,
no long-term data exist to support their use. An endoleak
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ported given the lack of complete graft apposition to the
aortic wall and the presence of gutters around the visceral
stents that run alongside the aortic graft.15,16,19-21 These
gutters often require additional procedures for repair.21
Snorkel and chimney grafts have also been associated
with an increased risk of stroke in the range of 3% to
10%.14-17,19 This increased risk is likely related to simulta-
neous bilateral upper extremity access and multiple cannu-
lations and catheter exchanges across the arch and
brachiocephalic vessels for the often multiple visceral ves-
sels needing concurrent stent placement.
Despite the prevalent use of upper extremity access, a
paucity of data on the complications apart from the local
access have been reported. Data on the risk of neurologic
complications after endovascular procedures requiring
upper extremity access are sparse. Coronary interventions
are frequently performed through the radial artery; how-
ever, no data could be found on the prevalence of neuro-
logic complications. The risk of CVA is known to be
increased in patients undergoing TEVAR with extension
further proximal into the arch and the presence of
atheroma.22,23 Scali et al24 found age >70 years, adjunc-
tive intraoperative procedures (visceral/brachiocephalic
stenting or concurrent debranching), peripheral artery
disease, coronary artery disease, and chronic obstructive
pulmonary disease all increased the risk of stroke after
TEVAR. Endovascular management of thoracic arch pa-
thology in high-risk surgical patients is associated with a
risk of stroke at 5% to 12%.20,25,26 This risk of stroke is
likely associated with the arch manipulation with wires
across the origins of the brachiocephalic vessels and the
underlying arch pathology.
Despite somewhat discouraging neurologic results
with chimney/snorkel grafts and endovascular arch repair,
upper extremity access for complex endovascular aortic
repairs does confer a number of advantages to the inter-
ventionist. Foremost, it allows the operator the option
of tackling a lesion or difﬁcult cannulation from an
entirely different approach. The caudal orientation of
the visceral vessels, most consistently the celiac artery
and SMA, is especially amenable to cannulation from
the upper extremity, avoiding difﬁculties in accessing the
vessel, and tracking wires and catheters for the placement
of stents. Tight angles, a small paravisceral aorta, and the
poor ability to track various catheters and stents compli-
cate access from the groin. There are a variety of tech-
niques to improve successful cannulation and stent
placement but can add signiﬁcant time, ﬂuoroscopy use,
and cost to the procedure. The signiﬁcant stress on the
visceral vessel using groin access, especially in diseased
vessels with ostial plaque, could also in theory increase
the rate of atheroembolism or dissection.
Access from the upper extremity allows catheteriza-
tion of multiple vessels from the arm, decreasing the
required size of sheath in the groin. Conversely, an 18F
to 22F sheath needs to be placed through the contralat-
eral femoral artery to the one used for the endograftplacement to allow access to the multiple vessels before
removal of the endograft constraining system. Given po-
tential difﬁculties cannulating the vessels, this sheath oc-
cludes the lower extremity vessels for a period of hours,
with the potential for embolization, reperfusion, and
distal ischemia.
Upper extremity access also allows the interventionist
the use of “body-ﬂossing,” a technique that allows a rail
system with wire access from the groin to the upper ex-
tremity (brachiofemoral access). This technique is crucial
for FEVAR after migrated EVAR grafts, those with a
type Ia endoleak, or those with proximal disease progres-
sion. Advancing a fenestrated endograft through a previous
EVAR endograft may be difﬁcult due to the loss of arterial
elasticity and inherent endograft rigidity. Moreover, fenes-
trated endograft manipulation for orientation may be
extremely difﬁcult once in place within a previous infrarenal
device. Having brachiofemoral access allows advancing the
endograft over a rail system with tension over the wire and
not the native vessels or previous endograft as well as easy
trackability and torquing of the device.
In our experience, a 12F angled Flexor Ansel Guiding
Sheath can successfully be placed and advanced using upper
extremity access in all cases. Local complications and
strokes were similar between those who did and did not
undergo upper extremity access, despite the additional
complexity. Juxtarenal aneurysms were more likely to
only require femoral access compared with more extensive
aneurysms. Upper extremity access was typically selected in
cases felt to be more difﬁcult, requiring additional adjuncts
for technical success. In this cohort, the aneurysms were
bigger, the patients were older, and the cases required a
more complex repair, as manifested by increased fenestra-
tions, blood loss, and longer operative times. Despite these
factors, the upper extremity access did not seem to increase
the risk for local or systemic complications.
Upper extremity access adds versatility to the practi-
tioner, allowing catheterization and wiring of up to four
vessels, if needed to be cannulated in succession alongside
each other within the sheath (buddy-wired) using a 0.035-
inch system. Early on in the series, 5F to 7F sheaths were
placed percutaneously; however, a bigger sheath was
needed to allow cannulation of multiple vessels, and a
switch to an open approach and larger sheath was per-
formed. In addition, we noted that the percutaneous access
had morbidity commonly associated with percutaneous
brachial artery access. Therefore, a shift was made to an
open high brachial artery technique, which afforded us
the ability to cannulate up to four vessels through a single
12F sheath, thus avoiding multiple passages of wires, cath-
eters, and sheaths across the arch and decreasing the risk of
stroke. The cutdown added little time in the overall case.
Because the 12F sheath was placed with one pass through
the arch, all further wires, catheters, and stents were pro-
tected, which likely reduced the risk of stroke to a mini-
mum. In addition, despite small numbers, right-sided
access and placement across the arch and all brachioce-
phalic vessels in this study did not appear to confer a higher
JOURNAL OF VASCULAR SURGERY
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was small.
Careful examination of the brachial artery with ultra-
sound is essential to assess location, presence of disease
or calciﬁcation, and anatomic variations with high bifur-
cations. Furthermore, thorough case planning with
three-dimensional reconstruction and multiplanar recon-
structions is essential to identify patients with anatomy
advantageous to upper extremity cannulation, avoiding
the hostile arch and those with concern for plaque
disruption.
Limitations of this study include the small sample size
of percutaneous and right-sided access from the upper ex-
tremity in this cohort, making any conclusions difﬁcult. A
further limitation was surgeon preference for selection of
patients who would be candidates for upper extremity ac-
cess. There was a potential selection bias because patients
thought to be at high risk for upper extremity access,
including those with unfavorable arch anatomy, aortic
thrombus, or signiﬁcant calciﬁc disease, underwent prefer-
ential femoral access. However, even with this potential
bias, those who underwent upper extremity access were
of a higher complexity compared with femoral access,
and no difference in morbidity was evident. We feel
strongly that success in upper extremity access lies in the
recognition of those patients who would not be good can-
didates and that a femoral approach should be performed
preferentially in these patients.
CONCLUSIONS
Upper extremity access appears to be a safe and feasible
approach for patients undergoing FEVAR. Open exposure
in the upper extremity may be safer than percutaneous ac-
cess during FEVAR. Unlike chimney and snorkel grafts,
upper extremity access during FEVAR is not associated
with an increased risk of stroke, despite the need for mul-
tiple visceral vessel stenting.
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should be congratulated for a well-designed study in which they
analyzed the outcome of upper extremity access in patients who
underwent fenestrated endovascular aortic aneurysm repair. In
this study, which spanned over a 5-year period, the authors re-
ported that 148 patients underwent fenestrated aortic aneurysm
repair, and 98 patients, or 66%, had upper extremity access.
Among them, 88% underwent open brachial artery cutdown, while
12% underwent percutaneous access. Access-related complications
occurred in four patients, resulting in an overall complication rate
of 4%, which included three hematomas and one stroke. The au-
thors concluded that upper extremity access is a safe and feasible
approach in patients undergoing fenestrated endovascular repair.
Furthermore, the authors noted that open exposure may be safer
than percutaneous access in these patient cohorts.
I have three questions for the author. First, the reported
complication rate in the literature on upper extremity access using
the snorkel or chimney technique in juxtarenal aortic aneurysm
repair is as high as 9%. In most of these reported series, the brachial
sheath typically ranged from 5F to 7F in size. In your study, you
reported that 12F brachial sheath was utilized in the majority of
your patients, with a remarkably low complication rate of 4%.
Can you explain this difference in outcomes in terms of using
larger brachial sheath with lower complications rates compared
with published reports?
Second, the operative time of fenestrated endovascular aortic
aneurysm repair in patients with brachial artery access is over
300 minutes, or more than 5 hours, in your series. Since you
used a 12F brachial introducer sheath in the majority of your pa-
tients, are there technical tips or tricks you can share in term of
minimizing the complication rate given the prolonged procedural
time with a 12F brachial sheath?
Third, open brachial artery cutdown was utilized in nearly 90%
of your patients who had upper extremity artery access, while
percutaneous technique was used in femoral artery access whereby
the introducer sheath ranged from 18F to 22F in size. Your group
has certainly demonstrated the expertise in previous publications in
managing introducer sheath of 22F in size percutaneously. Given
that you use a much smaller introducer sheath in the brachial ar-
tery, why can’t you perform brachial artery access percutaneously
under ultrasound guidance without a surgical cutdown?
I want thank Dr Knowles for an excellent presentation and
providing me with a well-written manuscript well ahead of time.
I also want to thank the Association for the opportunity to discuss
this paper.
Dr Martyn Knowles. Thank you very much for your thought-
ful questions and comments. The reason we found a decreased
complication rate with these 12F sheaths from the upper extremityis likely multifactorial. Preoperative meticulous evaluation of the
computed tomography angiogram and identiﬁcation of patients at
high-risk for complications is prudent. Additionally, careful intrao-
perative evaluation using ultrasound imaging ensures that the vessel
will tolerate the large sheath and avoids issues such as a small
brachial artery and a high radial artery take off. This allows the prac-
titioner the choice to select the contralateral side or decide upper
extremity access is too high-risk. Prior to accessing the brachial ar-
tery, we fully heparinize, keeping the activated clotting time above
300 for the whole case. We also feel very strongly about using a
micropuncture kit for vessel access, despite the open access, which
we feel decreases the local complication rate; namely, dissection.
Most importantly, however, the reason we likely have a lower
rate than that in chimney and snorkel cases is the avoidance of mul-
tiple passes of wires and catheters for multiple vessels across the
arch that those cases require. Our careful single pass into the
descending aorta with placement of the 12F sheath limits arch
manipulation and protects any further wire and catheter ex-
changes. Up to four 0.035-inch wires can be placed simultaneously
within the 12F sheath, allowing sequential cannulation and stent
placement, all with protection within the sheath. I really believe
this is the reason that the cerebrovascular complication rate in
this study was so low.
Referring to your second question, I have already mentioned a
fewof the tips forwhatwe feel decreases the complication rate. Addi-
tionally, aggressive heparinization and primary closure of the vessel,
with the ability to back-bleed, is paramount. Enough cannot be said
for careful planning on the preoperative computed tomography and
ultrasound, prior to accessing the vessel, to identify those with
treacherous arch disease or anatomy. Choosing a separate access
site or avoidanceoverall is important in the preventionof cerebrovas-
cular complications. Furthermore, having open access with the abil-
ity to primarily repair and ﬂush the vessel cuts down on local
complications.
To answer your last question, we do use predominantly percu-
taneous access for the groin access during fenestrated endovascular
aortic repair; however, we have been very hesitant to use percuta-
neous access for upper extremity access for a multitude of reasons.
We have performed percutaneous axillary access with 12F sheaths
in three patients with good results and no complications. Howev-
er, the concern is a very small amount of blood is needed to cause
brachial sheath hematoma and median nerve injury, which con-
cerns us greatly given its morbidity. Another reason is that with
the extensive operative times in this group, pulling a large sheath
without the ability to back-bleed and remove any debris or care-
fully repair the vessel is concerning. Overall, our results are good
with open exposure and in our experience does not add signiﬁcant
time to the operation.
